N/A
18 Years
85 Years
18 Years
85 Years
Not Enrolling
Both
Malignant Tumors
Both
Malignant Tumors
Trial Information
Inclusion Criteria
Inclusion criteria:
1. Consenting adults aged ≥ 18 years.
2. Recurrent or progressive high grade glioma after failure of at least one line of
standard oncological treatment.
3. Gliomatosis cerebri, including patients declining radiation treatment.
Exclusion criteria:
1. Patients with malignant tumors who are receiving treatment at the time of the
recruitment.
2. Early termination - patients who will wish to stop their participation in the trial
will discontinue the ketogenic diet and return to their usual diet.
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Outcome Measure:
To study the effect of the ketogenic diet on tumor growth progression and longevity in patients with Malignant glioblastoma.
Outcome Description:
This will be done by comparing tumor size by repeated MRI studies (every 2 months)
Safety Issue:
No
Authority:
Israel: Ministry of Health
Study ID:
TASMC-09-NV-0056-CTIL
NCT ID:
NCT01092247
Start Date:
March 2010
Completion Date:
September 2011
Related Keywords:
- Malignant Tumors
- Patients with malignant tumors
- Neoplasms
Name | Location |
|---|
